Bronchodilator Responsiveness in Obliterative Bronchiolitis
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study has been designed to provide a substantial evidence of acute bronchodilator
responsiveness to two sequentially inhaled drugs, a beta2-agonist (i.e., albuterol) and an
anticholinergic (i.e., tiotropium bromide), in a group of patients who developed obliterative
bronchiolitis after hematopoietic stem cell transplantation.
Phase:
Phase 4
Details
Lead Sponsor:
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy